Harold Wanebo, MD
Emeritus Professor
Boston University Chobanian & Avedisian School of Medicine
Surgical Oncology

MD, University of Colorado Boulder
BS, Regis College

Dr. Wanebo is Emeritus Professor of Surgery in the surgical oncology section at Roger Williams Medical Center, an affiliate of Chobanian and Avedisian School of Medicine. Dr. Harold Wanebo has spent years training, teaching, and working as a surgical oncologist. He eventually moved into consulting and has delivered over 500 presentations and authored 290 peer reviewed journal articles. His research interests include surgical oncology, hepatobiliary surgery, colorectal surgery and gastrointestinal cancer management and pelvic malignancy surgery. He has been affiliated with numerous professional organizations throughout his academic career including the American College of Surgeons, the American Association for Cancer Research, the New England Surgical Society and many others.

Harold J. Wanebo, MD, FACS, attended the University of Colorado Denver School of Medicine. Following his graduation in 1961, he went on to intern at Cornell University in Ithaca, New York, and serve his surgical residency training at the University of California, San Francisco, and Memorial Sloan Kettering Cancer Center, where he trained in tumor immunology. Dr. Wanebo is a board certified in general surgery with the American Board of Surgery. He is an active member of the American Head and Neck Society, the Society of Surgical Oncology, and the American Society of Clinical Oncology. Dr. Wanebo is an extensively published author and has spent 2 years in the army with 1 year in Vietnam. As a result of his outstanding performance in the field of surgical oncology, The International Association of HealthCare Professionals (IAHCP) has selected Harold J. Wanebo, MD, FACS, to be featured in the premier publication of The Leading Physicians of the World.

Roger Williams Medical Center

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Stephen AH, Fallon EA, Kalife E, Wanebo H. Radiation-associated sarcoma after recurrent colorectal primary tumor: A complex surgical case. J Surg Oncol. 2015 Nov; 112(6):658-61. PMID: 26430853; DOI: 10.1002/jso.24059;
  2. Wanebo HJ, Lee J, Burtness BA, Ridge JA, Ghebremichael M, Spencer SA, Psyrri D, Pectasides E, Rimm D, Rosen FR, Hancock MR, Tolba KA, Forastiere AA. Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303). Ann Oncol. 2014 Oct; 25(10):2036-41. PMID: 25009013; PMCID: PMC4176450; DOI: 10.1093/annonc/mdu248;
  3. Psyrri A, Lee JW, Pectasides E, Vassilakopoulou M, Kosmidis EK, Burtness BA, Rimm DL, Wanebo HJ, Forastiere AA. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303. Clin Cancer Res. 2014 Jun 1; 20(11):3023-32. PMID: 24700741; PMCID: PMC4049169; DOI: 10.1158/1078-0432.CCR-14-0113;
  4. Birnbaum A, Dipetrillo T, Rathore R, Merriam P, Wanebo H, Thomas A, Puthawala Y, Joyce D, Luppe D, Khurshid H, Follett N, Sio TT, Safran H. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a survival analysis of a Brown University Oncology Group phase II study. Am J Clin Oncol. 2014 Apr; 37(2):162-6.View Related Profiles. PMID: 23275269; DOI: 10.1097/COC.0b013e31826e06e0;
  5. Best C, Calianese D, Szulak K, Cammarata G, Brum G, Carbone T, Still E, Higgins K, Ji F, DI W, Wanebo H, Wan Y. Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death. Oncol Lett. 2013 Jun; 5(6):1854-1858. PMID: 23833655; PMCID: PMC3701061; DOI: 10.3892/ol.2013.1305;
  6. Wu CH, Cao C, Kim JH, Hsu CH, Wanebo HJ, Bowen WD, Xu J, Marshall J. Trojan-horse nanotube on-command intracellular drug delivery. Nano Lett. 2012 Nov 14; 12(11):5475-80. PMID: 23030797; PMCID: PMC4106035; DOI: 10.1021/nl301865c;
  7. Wanebo HJ, LeGolvan M, Paty PB, Saha S, Zuber M, D'Angelica MI, Kemeny NE. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 2012 Oct; 29(7):821-39. PMID: 23053740; DOI: 10.1007/s10585-012-9517-x;
  8. Karakousis CP, Wanebo H. Pelvic surgery. Int J Surg Oncol. 2012; 2012:287096. PMID: 23029608; PMCID: PMC3458292; DOI: 10.1155/2012/287096;
  9. Ready NE, Rathore R, Johnson TT, Nadeem A, Chougule P, Ruhl C, Radie-Keane K, Theall K, Wanebo HJ, Marcello J, Kennedy T. Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2012 Feb; 35(1):6-12.View Related Profiles. PMID: 21293244; DOI: 10.1097/COC.0b013e3182019ee3;
  10. White RL, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F, Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP. Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database. Ann Surg Oncol. 2011 Dec; 18(13):3593-600. PMID: 21647761; PMCID: PMC3461951; DOI: 10.1245/s10434-011-1826-9;
Showing 10 of 253 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 224 publications over 36 distinct years, with a maximum of 17 publications in 1996


Contact for Mentoring:

25 Buick St
Boston MA 02215
Google Map

Wanebo's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department